Catheter Precision becomes Flyte Aviation with 1-for-10 reverse split Oct 5; ticker switches to VJET

Catheter Precision, Inc.

Stockholders approved the 1-for-10 reverse split and name change to Flyte Aviation, Inc.; shares drop from ~21,019,874 to ~2,101,987, trading as VJET on NYSE American from Oct 5, 2026.
Option repricing approved: options struck above fair market value repriced to $0.152/share (Sept 30 close), $1.52 post-split; CEO Jenkins held 89,999 options, CFO Anderson 66,315.
2023 Equity Incentive Plan amended to add 5,000,000 shares; stockholders also cleared issuance of up to 340,000 shares on Series M warrants and a Series J preferred conversion-price cut (floor $0.23).
David A. Jenkins elected Class II director (9,640,603 for vs 301,162 withheld) for a term to 2029; WithumSmith+Brown ratified as auditor for FY2027.
Reincorporation from Delaware to Nevada by plan of conversion approved; authorized capital unchanged at 500M common and 10M preferred shares. No fractional shares; Equiniti is exchange agent.

item 3.03 item 5.03 item 5.02 item 5.07 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.